Interleukin‐6: A Cytokine for Gerontolgists

Journal of the American Geriatrics Society

Volumn 41, Issue 2, 1993, Pages 176-181

  Ershler, William B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ESTROGEN; INTERLEUKIN 6; INTERLEUKIN RECEPTOR;

AGING; ALZHEIMER DISEASE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; LYMPHOMA; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; REVIEW; T LYMPHOCYTE;

AGING; ALZHEIMER DISEASE; ANIMAL; GENE EXPRESSION; GERIATRICS; HUMAN; INTERLEUKIN-6; OSTEOPOROSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027503291     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1993.tb02054.x     Document Type: Article

References (64)

1. Interleukin‐6: An overview
2. Age‐related monoclonal gammopathies: Clinical lessons from the aging C57BL mouse
3. Immunoglobulin patterns in humans over 95 years of age
4. Contributions of recent research to the classification of spontaneous lymphoid cell neoplasms in mice
5. − protein. Amyloid and cell localization of α1‐antichymotrypsin
6. Is amyloidogenesis during Alzheimer's disease due to an IL‐1/IL‐6‐mediated “acute phase response” in the brain?
7. IL‐6 is produced by osteoblasts and induces bone resorption
8. Interleukin‐6: An osteoporotic factor?
9. 17B‐Estradiol inhibits interleukin‐6 production by bone marrow‐derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens
10. Increased osteoclast development after estrogen loss: Mediation by Interleukin‐6
11. Autocrine generation and requirement of BSF/2/IL‐6 for human multiple myelomas
12. Paracrine rather than autocrine regulation of myeloma—Cell growth and differentiation by IL‐6
13. Decrease in BSF2/IL‐6 response in advanced cases of multiple myeloma
14. Serum levels of interleukin‐6 in multiple myeloma and other hematologic disorders: Correlation with disease activity and other prognostic parameters
15. Cytokine expression in T‐cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth
16. Dual control of CRP gene expression by interleukin‐1 and interleukin‐6
17. B cell stimulatory factor 2 (β2‐interferon) functions as a second signal for interleukin‐2 production by mature murine T cells
18. Dysregulated interleukin‐6 expression produces a syndrome resembling Castleman's disease in mice
19. Pathogenic significance of interleukin‐6 (IL‐6/BSF‐2) in Castleman's disease
20. Constitutive production of interleukin‐6 and immunologic features in cardiac myxoma
21. Human chromosome 7 carries the β2‐interferon gene
22. Structure and expression of cDNA and genes for human interferon β2, a distinct species inducible by growth‐stimulatory cytokines
23. Structure and expression of human B cell stimulatory factor‐2 (BSF‐2/IL‐6) gene
24. Murine hybridoma/plasmacytoma growth factor: Complete amino acid sequence and relation to human interleukin‐6
25. Monocyte‐derived human B‐cell growth factor identified as interferon β‐2 (BSF‐2, IL‐6)
26. Interleukin‐6 enhancement of interleukin‐3 on development of multipotential hemopoietic progenitors
27. Rapid enhancement of β2‐interferon/B‐cell differentiation factor BSF‐2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187
28. Synthesis of interleukin‐6 (interferon‐b2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP
29. Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin‐1 in human fibroblasts: Role in the induction of interleukin‐6
30. Cloning and expression of the human interleukin‐6 (BSF‐2/IL‐6) receptor
31. Interleukin‐6 triggers the association of its receptor with a possible signal transducer, gpl30
32. Molecular cloning and expression of an IL‐6 signal transducer, gpl30
33. Structure and expression of human B cell stimulatory factor‐2 (BSF‐2/IL‐6) gene
34. Genomic structure of the murine IL‐6 gene: High degree of conservation of potential regulatory sequences between mouse and human
35. Interleukin‐6 (IL‐6)
36. A possible autocrine role for interleukin‐6 in two lymphoma cell lines
37. Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal carcinomas
38. Interleukin‐6 produced by renal cell carcinoma cells and progression of multiple myeloma
39. Interleukin‐6 is the central tumor growth factor in vitro and in vivo in multiple myeloma
40. Age‐associated increase in interleukin‐6 in MRL/1pr mice
41. Influence of age and caloric restriction on macrophage IL‐6 and TNF production
42. Fever, tumor necrosis factor and interleukin‐6 in young, mature and aged Fischer 344 rats
43. Classification and incidence of hyperplastic and neoplastic hemopoietic lesions in mice
44. Experimental models of lymphoproliferative disease: The mouse as a model for human non‐Hodgkin's lymphomas and related leukemias
45. Immunomorphologic classification of spontaneous lymphoid cell neoplasms in female BALB/C mice
46. Spontaneous lesions in virgin and retired breeder BALB/c and C57BL/6 mice
47. Antitumor activity of recombinant interleukin‐6 in mice
48. In vivo and in vitro characteristics of interleukin‐6 transfected B16 melanoma cells
49. Multiple actions of interleukin‐6 within a cytokine network
50. Letter to the editor The bone‐resecting activity of interleukin‐6
51. Reply The bone‐resorbing activity of interleukin‐6
52. Interleukin‐6 does not stimulate bone resorption in neonatal mouse calvariae
53. IL‐6 stimulates osteoclast‐like multinucleated cell formation in long term human marrow cultures by inducing IL‐1 release
54. Interleukin‐6 causes hypercalcemia in vivo, and enhances the bone resorbing potency of interleukin‐1 and tumor necrosis factor by two orders of magnitude in vitro
55. 17β estradiol regulates IL‐6 production and osteoclast development in murine calvaria cell cultures
56. Demonstration of estrogen receptors by Western blot analysis in bone marrow stromal cells and osteoblasts: Correlation with interleukin‐6 regulation by estrogens and antiestrogens
57. 17β‐estradiol has no effect on IL‐1B and TNF stimulated IL‐6 production in normal human osteoblast‐like cells
58. Alzheimer's disease: The amyloid cascade hypothesis
59. Alzheimer's disease: A cell biological perspective
60. In vitro matured macrophages express Alzheimer's βA4‐amyloid precursor protein indicating synthesis in microglial cells
61. Alpha 2‐macroglobulin synthesis in interleukin‐6‐stimulated human neuronal (SH‐SY5Y neuroblastoma) cells: Potential significance for the processing of Alzheimer β‐amyloid precursor protein
62. 2‐macroglobulin immunoactivity in cortex and hippocampus of Alzheimer's disease patients
63. IL‐6‐mediated events in Alzheimer's disease pathology